Materialise and Siemens Healthineers syngo.via Partner to Bring 3D Printing to Hospitals Worldwide
November 27 2017 - 8:00AM
Business Wire
Partnership with Siemens Healthineers expands availability of
Materialise Mimics inPrint software
Materialise NV (Nasdaq:MTLS), a leading provider of 3D printing
services and software solutions, and Siemens Healthineers, a
leading medical technology company announced today that they are
joining forces to bring Materialise Mimics inPrint software to
hospitals around the world. 3D printing technology is growing
rapidly in the medical field, and soon it will be even more
mainstream as 3D printing software becomes more accessible in
hospitals. The partnership, announced at the 2017 Radiological
Society of North America (RSNA) Annual Meeting, makes Materialise
Mimics inPrint software, a dedicated solution for printing
anatomical models in hospitals, available to radiologists through
the Siemens Healthineers syngo.via open app platform.
Adopting virtual 3D anatomical models facilitates surgical
planning and collaboration between radiologists and surgical teams.
3D-printed anatomical models improve patient communication,
training and education surrounding anatomically complex
pathologies.
“We believe 3D printing is going to revolutionize the medical
industry and we are always looking for ways to improve
accessibility of our 3D printing software to more patients and
hospitals,” said Brigitte de Vet, Vice President of Medical at
Materialise. “By partnering with other global healthcare leaders
like Siemens Healthineers, we can do just that, and more
importantly, we can further contribute to a better and healthier
world.”
By integrating the software into syngo.via, Mimics inPrint is
directly incorporated into the standard hospital workflow. This
allows for safe and easy access to in-house and Materialise-powered
3D printing services. This will facilitate the integration of 3D
printing within clinical environments, contributing to higher
quality, cost-efficient care for patients and hospitals. Each
patient will now have access to more personalized care through
Materialise’s patient-specific anatomical models.
“By incorporating 3D technology into syngo.via, we jointly
support the entire workflow from patient diagnosis to therapy
planning,” said Valentin Ziebandt, Head of Marketing at the Syngo
Business Line at Siemens Healthineers. “This is a cost-effective
way to increase the clinical capabilities of syngo.via and an
important step towards achieving personalized care and precision
medicine.”
For more information on this partnership and the Materialise
Mimics inPrint software visit
www.materialise.com/en/medical/3d-printing-introduced-into-your-workflow
or stop by the Materialise booth, #7932 in the North - Hall B,
during the 2017 RSNA Annual Meeting at McCormick Place in Chicago
from November 26 – December 1.
About MaterialiseMaterialise incorporates 27 years of 3D
printing experience into a range of software solutions and 3D
printing services, which together form the backbone of the 3D
printing industry. Materialise’s open and flexible solutions enable
players in a wide variety of industries, including healthcare,
automotive, aerospace, art and design, and consumer goods, to build
innovative 3D printing applications that aim to make the world a
better and healthier place. Headquartered in Belgium, with branches
worldwide, Materialise combines the largest group of software
developers in the industry with one of the largest 3D printing
facilities in the world. For additional information, please visit:
www.materialise.com.
About Materialise’s Medical DivisionMaterialise Medical,
which has pioneered many of the leading medical applications of 3D
printing, enables researchers, engineers and clinicians to
revolutionize innovative patient-specific treatment. Materialise
Medical’s open and flexible platform of software and services,
Materialise Mimics, form the foundation of certified Medical 3D
Printing, in clinical as well as research environments, offering
virtual planning software tools, 3D-printed anatomical models, and
patient-specific surgical guides and implants. For additional
information, please visit:http://hospital.materialise.com/
Cautionary Statement on Forward-Looking StatementsSome of
the statements in this press release are "forward-looking" and are
made pursuant to the safe harbor provision of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include statements relating to, among other things, our
planned commercialization efforts and regulatory approvals of our
technologies as well as the success thereof and our research and
development projects. These forward-looking statements are based
upon the expectations of management under current assumptions at
the time of this press release. We caution you that forward-looking
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that are
in some cases beyond our control that may cause our actual results
to differ materially from our expectations. We are providing this
information as of the date of this press release and do not
undertake any obligation to update any forward-looking statements
contained in this presentation as a result of new information,
future events or otherwise, unless we have obligations under the
federal securities laws to update and disclose material
developments related to previously disclosed information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171127005474/en/
Press:MaterialiseVirginia Goble, Phone:
734.259.6445Mobile : 248.921.5500Vice President
Marketing-North AmericaEmail:
virginia.goble@materialise.comTwitter: @MaterialiseNVVisit:
www.materialise.comorFrancoDan Horn, Phone:
313.567.5008Mobile: 313.410.3992Email: horn@franco.com
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Apr 2023 to Apr 2024